Novartis India Ltd — Others, 31-07-2025: AGM/EGM

Novartis India held its 77th Annual General Meeting (AGM) via video conferencing. Key items transacted included the adoption of the audited financial statements for the fiscal year ended March 31, 2025. Shareholders also approved the final dividend for the same period. Additionally, Mr. Falin Majmudar was re-appointed as a Director, and M K Saraf & Associates LLP were appointed as Secretarial Auditors for the company. The meeting provided a forum for shareholder queries, which were addressed. The combined e-voting results will be shared soon.